Sector: Health & pharmaceuticals

Are class action waiver clauses unfair under the UCT regime in the Australian Consumer Law?...

Read More →

Bringing balance to indemnity clauses

May 1, 2023 | 0 Comments

How to ensure indemnity and limitation of liability clauses comply with the Unfair Contract Terms regime...

Read More →

Greenwashers must scrub up

March 2, 2023 | 0 Comments

ACCC releases report on greenwashing claims...

Read More →

The ACCC’s draft determination is notable as the first occasion on which a pharmaceutical settlement and licence agreement has been considered in the authorisation context in Australia. The scepticism with which the ACCC approached the...

Read More →

Concerns about the price of rapid antigen tests prompts ACCC examination of costs and retail prices in a bid to prevent the development and spread of excessive pricing practices amongst retailers for these essential pandemic...

Read More →

Scaffold for criminal charges fails

August 20, 2021 | 0 Comments

On 17 August 2021, the Commonwealth Director of Public Prosecutions (CDPP) withdrew criminal cartel charges against the Construction, Forestry, Maritime, Mining and Energy Union (CFMMEU) and its Australian Capital Territory (ACT) Divisional Branch Secretary, Mr...

Read More →

Pharmaceutical company Alkaloids of Australia and its former export manager charged with criminal cartel offences following ACCC investigation...

Read More →

ACCC moves quickly to provide immunity for coordination during COVID...

Read More →

Pay-for-delay pharmaceutical agreements have attracted scrutiny from regulators in the US and EU. With last year's repeal of the intellectual property exemption in the CCA, these agreements are at greater risk of Australian regulatory attention...

Read More →

Commonwealth to punish profiteers: New prohibitions against price gouging and export of medical supplies during COVID-19 crisis...

Read More →